Bahrain approves Sinopharm vaccine for children aged 3-11
Doses of the Chinese Sinopharm vaccine against the coronavirus disease (COVID-19) are seen at a restaurant in Kragujevac, Serbia, May 4, 2021. REUTERS/Marko Djurica/File Photo
Register now for FREE unlimited access to Reuters.com
DUBAI, Oct 26 (Reuters) - Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years from October 27, the state media office said on Tuesday.
The Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11, it also said.
Register now for FREE unlimited access to Reuters.com
Reporting by Alexander Cornwell;
Editing by Andrew Cawthorne
Our Standards: The Thomson Reuters Trust Principles.